NAMPT and colorectal carcinoma: Human DLD-1 CRC cells were kept as control or treated with visfatin (25, 50, and 100 ng/mL) for 6, 12, and 24 h and then the mRNA and protein expression of TYMS were examined by real-time PCR and Western blot, respectively.